Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
78
-
Total shares
-
11.6M
-
Shares change
-
+4.43M
-
Total reported value, excl. options
-
$70M
-
Value change
-
+$25.6M
-
Put/Call ratio
-
0.53
-
Number of buys
-
51
-
Number of sells
-
-32
-
Price
-
$6.03
Significant Holders of CureVac N.V. - COM (CVAC) as of Q4 2022
85 filings reported holding CVAC - CureVac N.V. - COM as of Q4 2022.
CureVac N.V. - COM (CVAC) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (1.98M shares), Bill & Melinda Gates Foundation (1.63M shares), Balyasny Asset Management LLC (1.4M shares), BlackRock Inc. (1.21M shares), MILLENNIUM MANAGEMENT LLC (866K shares), MARSHALL WACE, LLP (595K shares), PRICE T ROWE ASSOCIATES INC /MD/ (554K shares), NORGES BANK (491K shares), MORGAN STANLEY (337K shares), and STATE STREET CORP (257K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.